-
Mashup Score: 2Nanostics and Protean BioDiagnostics Partner to Launch CDX Prostate for Men at Risk of Having Aggressive Prostate Cancer in the United States - 2 month(s) ago
Nanostics and Protean partner to offer CDX Prostate risk score as a diagnostic tool to men suspected of having aggressive prostate cancer in the USA.
Source: www.businesswire.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 1Nanostics and Protean BioDiagnostics Partner to Launch CDX Prostate for Men at Risk of Having Aggressive Prostate Cancer in the United States - 3 month(s) ago
Nanostics and Protean partner to offer CDX Prostate risk score as a diagnostic tool to men suspected of having aggressive prostate cancer in the USA.
Source: www.businesswire.comCategories: General Medicine News, General HCPsTweet-
We are excited to be able to provide CDX Prostate as part of our cancer screening program https://t.co/WR5rstO7OS
-
-
Mashup Score: 0The Indispensable Role of Pathologists - 3 month(s) ago
Dr. Tony Magliocco of the Moffit Cancer Center joins us to discuss the indepensible role of pathologists in precision medicine and the importance of technology to support clinical decision making.
Source: www.trapelohealth.comCategories: General Medicine News, General HCPsTweet-
Listen to The Indispensable Role of Pathologists to the Future of Precision Oncology on the Precision Medicine Podcast sponsored by trapelo https://t.co/EvmUMNdRjx
-
-
Mashup Score: 1Cancer of Unknown Primary – what does it mean? - 4 month(s) ago
Anthony Magliocco, MD is a cancer expert with over 30 years of experience.In this video he explains why someone might be diagnosed with a ‘cancer of unknown …
Source: www.youtube.comCategories: General Medicine News, General HCPsTweet-
Cancer of Unknown Primary – what does it mean? https://t.co/Y31cedLkX4 via @YouTube
-
-
Mashup Score: 1Protean MAPS™ Improves the Delivery of Precision Health Information to Community Oncology Practices — Protean BioDx - 6 month(s) ago
Protean and Roche have created a novel project to accelerate access to precision oncology for community based oncology programs.
Source: www.proteanbiodx.comCategories: General Medicine News, General HCPsTweet-
RT @proteanbiodx: Protean and Roche have created a novel project to accelerate access to precision oncology. https://t.co/v1Qn0QquGX https:…
-
-
Mashup Score: 1Dyson spheres: Could alien megastructures exist in the Milky Way? Scientists found 7 places to look | CNN - 6 month(s) ago
New research suggests stars in the Milky Way give off infrared heat expected from Dyson spheres, which physicist Freeman Dyson theorized could be created by intelligent life.
Source: www.cnn.comCategories: General Medicine News, General HCPsTweet-
Check out this article: It’s difficult for us to find an explanation for these sources,” he said. “They could be Dyson spheres, because they behave like our models predict, but they could be something else as well" https://t.co/kiP49ifhmO
-
-
Mashup Score: 0Cancer Informant - 8 month(s) ago
Cancer Informant is a podcast made to inform cancer patients and their loved ones about their options for cancer testing and treatment. Dr. Tony Magliocco is a cancer expert with over 30 years of experience. He will explore topics frequently surrounded by confusion, and will answer questions directly from you!
Source: www.youtube.comCategories: General Medicine News, General HCPsTweet-
Visit Cancer Infomant now in video on YouTube https://t.co/GKb57T5NJn
-
-
Mashup Score: 0How is prostate cancer detected? #prostatecancer #cancerscreening - 8 month(s) ago
Learn more about how prostate cancer is detected, risk factors, and treatments on our full video. Watch the full video on prostate cancer by clicking the rel…
Source: www.youtube.comCategories: General Medicine News, General HCPsTweet-
https://t.co/aWs7qCAUqr
-
-
Mashup Score: 1Aventa Genomics introduces NGS test for solid tumours - 9 month(s) ago
Aventa Genomics has launched its next-generation sequencing (NGS) test, Aventa FusionPlus, to identify gene fusions and translocations.
Source: www.medicaldevice-network.comCategories: General Medicine News, General HCPsTweet-
Aventa Genomics introduces NGS test for solid tumours https://t.co/9wXvGlEWnJ via @MedicalTechMag
-
-
Mashup Score: 1Aventa Genomics Announces Launch of Aventa FusionPlus, the First 3D Genomics Clinical Test for Patients with Solid Cancers - 1 year(s) ago
Aventa Genomics, a joint venture of Arima Genomics and Protean BioDiagnostics, launched the Aventa FusionPlus test for patients with solid cancers.
Source: www.businesswire.comCategories: Healthcare Professionals, Latest HeadlinesTweet-
We are happy to make this innovative, clinically impactful, precision laboratory developed diagnostic test available to treating physicians for the benefit of their patients. https://t.co/rIuYm5Dfu0
-
We are excited to be able to provide CDX Prostate as part of our cancer screening program https://t.co/WR5rstO7OS